Clinical trial
S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma
NCT00109889 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00109889 |
|---|---|
| Title | S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma |
| Official title | A Prospective Observational Study of Patients With Solitary Plasmacytoma Using a Modified Staging System Supplemented by an MRI and Whole Body FDG-PET Scan |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Plasmacytoma |
| Intervention type | Procedure |
| Interventions | magnetic resonance imaging, positron emission tomography |
| Enrollment | 2 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | May 4, 2005 |
| Last update posted | Apr 24, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: